Full Breakdown
Urgent Recall of Rhino Choco VIP 10X Due to Undeclared Erectile Dysfunction Drug
3/1/2026, 6:23:11 AM
Core Event: Recall of Rhino Choco VIP 10X
USALESS.COM has initiated an urgent recall of its Rhino Choco VIP 10X chocolate male enhancement supplement after federal health officials discovered the product contains Tadalafil, the active ingredient in the prescription medication Cialis. This undeclared ingredient poses significant health risks, particularly for individuals taking nitrates for conditions such as diabetes, high blood pressure, high cholesterol, or heart disease.
Product Details and Health Risks
The recall affects the 10-gram, 12-piece chocolate supplement packaged in a black cardboard box, which has an expiration date of October 2027. The product is sold both online and in retail stores. Tadalafil is classified as a phosphodiesterase type-5 (PDE-5) inhibitor and is not permitted in over-the-counter products. The FDA has emphasized that products containing Tadalafil cannot be marketed as dietary supplements, which are less regulated than prescription medications.
The presence of Tadalafil can lead to dangerous interactions with nitrates, potentially causing a severe drop in blood pressure. This risk is particularly concerning for individuals who are already on medications for heart-related conditions. Although no adverse health events have been reported in connection with this recall, the FDA warns that combining Tadalafil with nitrates can result in dizziness, fainting, heart attack, or stroke.
Official Statements & Responses
In its announcement, USALESS.COM stated, "The product has been immediately removed from our online store until we are certain that the problem has been corrected." The company is urging consumers who purchased the Rhino Choco VIP 10X to return it for a full refund. The FDA has previously cautioned against the use of "Rhino"-branded male enhancement products due to health risks associated with hidden drugs.
Criticism & Opposition
The FDA's limited regulatory oversight of dietary supplements has drawn criticism, particularly in light of repeated incidents involving undeclared prescription drugs in such products. Critics argue that supplement manufacturers should face stricter penalties for endangering consumer health by concealing harmful ingredients.
Conflicting Reports & Gaps
While the recall is a response to the discovery of Tadalafil in Rhino Choco VIP 10X, a similar incident occurred in December involving StuffbyNainax LLC, which recalled MR.7 SUPER 700000 capsules after testing revealed the presence of both Tadalafil and Sildenafil, the active ingredient in Viagra. However, the specifics surrounding the initiation of that recall remain unclear.
What's Next
As the situation develops, USALESS.COM is expected to implement corrective measures to prevent future occurrences of similar issues. The FDA continues to monitor the market for dietary supplements to ensure consumer safety and compliance with regulations.
